Global Information Lookup Global Information

Aerie Pharmaceuticals information


Aerie Pharmaceuticals
Company typeSubsidiary
Traded as
Nasdaq: AERI
Industry
  • Pharmaceuticals
  • Ophthalmology
Founded2005; 19 years ago (2005)
Founders
  • David L. Epstein
  • Casey C. Kopczynski
HeadquartersDurham, North Carolina, U.S.
ParentAlcon
Websiteaeriepharma.com

Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients with glaucoma or ocular hypertension.[1][2][3]

In August 2022, Swiss eye-care firm Alcon agreed to buy Aerie Pharmaceuticals for US$770 million.[4] The acquisition completed in November 2022.[5]

  1. ^ Witkowski, Wallace (16 September 2015). "Aerie Pharma Shares Skyrocket On Glaucoma Drug Study Results". Fox Business.[permanent dead link]
  2. ^ Beckerman, Josh (16 September 2015). "Aerie Pharmaceuticals Shares Rise on Trial Results". Wall Street Journal.
  3. ^ "Aerie Pharma shares battered as eye drug fails study". Reuters. 23 April 2015. Retrieved 7 January 2016.
  4. ^ "Alcon buys the American Aerie Pharmaceuticals for 770 million". Swissinfo (in French). 23 August 2022.
  5. ^ Ezzone, Zac (23 November 2022). "Durham loses public company HQ with Alcon-Aerie deal complete". American City Business Journals. Archived from the original on 1 December 2022.

and 10 Related for: Aerie Pharmaceuticals information

Request time (Page generated in 0.7611 seconds.)

Aerie Pharmaceuticals

Last Update:

Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the...

Word Count : 172

Alcon

Last Update:

traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye...

Word Count : 959

List of biotech and pharmaceutical companies in the New York metropolitan area

Last Update:

Adma Biologics Aerie Pharmaceuticals AIM ImmunoTech Akorn Akrimax Allergan Alvogen Amarin Amicus Therapeutics Amneal Pharmaceuticals Angel Medical Systems...

Word Count : 1320

Russell Microcap Index

Last Update:

Industries (Nasdaq: PATK) Synergy Pharmaceuticals (Nasdaq: SGYP) Hanmi Financial (NYSE: HAFC) Aerie Pharmaceuticals (Nasdaq: AERI) Stewart Information...

Word Count : 292

Foresite Capital

Last Update:

companies such as Acceleron Pharma, Aimmune, Alumis, ALX Oncology, Aerie Pharmaceuticals, Ascendis, Blueprint Medicines, CG Oncology, Color Genomics, Cue...

Word Count : 895

Alta Partners

Last Update:

Stage) Notable investments include Kite Pharmaceuticals, ZS Pharma, Esperion, Allakos Chemgenx, DeCode Calistoga, Aerie, Cymabay, and Tyra Biosciences. Burr...

Word Count : 410

International Vaccine Institute

Last Update:

GlaxoSmithKline Gyeongbuk Institute for Bio Industry Incepta Pharmaceuticals Inovio Pharmaceuticals Instituto Butantan Merck Pfizer Sanofi Shantha Biotechnics...

Word Count : 2483

Mariagrazia Pizza

Last Update:

pandemia". Rotary Bologna Galvani (in Italian). Retrieved 2023-06-15. Em, Aerie (2023-03-09). "Profs. Andrew Pollard / Sarah Gilbert and Drs. Rino Rappuoli...

Word Count : 626

220 Central Park South

Last Update:

Ricciulli, Valeria (January 22, 2020). "At 220 Central Park South, four-bedroom aerie lists for $36M". Curbed NY. Archived from the original on October 31, 2020...

Word Count : 7203

Advertising

Last Update:

politicized.[need quotation to verify] There are some companies like Dove and aerie that are creating commercials to portray more natural women, with less post...

Word Count : 14036

PDF Search Engine © AllGlobal.net